Definitive Contract 75F40124C00084

Award Date 8/27/24
Potential Completion Date 8/26/26
Potential Value $324K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a cost-no-fee definitive contract awarded by the Food and Drug Administration (FDA) to The Johns Hopkins University, a private research university, for the "Development of an Automated and Sustainable Electronic Approach for Data Mining to Evaluate Clinical Outcomes of Patients with Bacterial Infections." The $263,718.87 contract has a completion date of June 30, 2020 and is not set aside. The Johns Hopkins University has a history of providing clinical trial coordination, data...
This is a $911,251 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to The Johns Hopkins University to improve the efficiency and rigor of pharmacovigilance at the FDA. The contract involves developing a cognitive framework for case series evaluation and integrating it into the FDA's information visualization platform to support decision-making. This contract does not have a set-aside designation. The Johns Hopkins University, a private research university...
This firm-fixed-price definitive contract was awarded by the Food and Drug Administration (FDA) to The Johns Hopkins University, a private non-profit research university, to improve the efficiency and rigor of pharmacovigilance at the FDA. The $926,349 contract has a period of performance through September 30, 2023, and was awarded on September 22, 2021 under Broad Agency Announcement HDDISWP 134. No set-aside was used for this award. The contract allows The Johns Hopkins University to provide...
The Department of Health and Human Services Food and Drug Administration awarded a $25,000.00 firm fixed price purchase order to The Johns Hopkins University, a private, non-profit research university, to develop human intestinal organoids/colonoids cell lines. The contract does not have a set-aside designation and was awarded on March 31, 2021 with a completion date of June 30, 2021. The Johns Hopkins University is a leading research institution that has received numerous prime and subcontracts...
The U.S. Department of Health and Human Services Food and Drug Administration awarded a $347,261.89 firm fixed-price definitive contract to The Johns Hopkins University, a private research university, to evaluate device-related immune response unique to material and psychological location. This contract does not have a set-aside designation. The Johns Hopkins University is a well-established provider of biomedical research, public health initiatives, and scientific analysis services to federal...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order valued at three hundred forty-four thousand six hundred ninety-seven dollars and fifty cents ($344,697.50) to The Johns Hopkins University. The Johns Hopkins University will provide all deliverables to the Contracting Officer's Representative. Under this contract, Nanostring Technologies, Inc. was awarded a subcontract valued at an undisclosed amount to supply nCounter Master Kit...
This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to The Johns Hopkins University on August 30, 2017 for $100,000.00. The contract has an ultimate completion date of October 31, 2017 and is not set aside. The Johns Hopkins University is a private, non-profit research university that has extensive experience providing clinical trial and data coordination, statistical analysis, IT and software development, research and lab...
The Food and Drug Administration awarded a $307,205 cost-no-fee contract to The Johns Hopkins University under Broad Agency Announcement PMWP#173 to evaluate the impact of extended-infusion beta-lactam administration strategies on improving clinical outcomes and reducing the subsequent emergence of antimicrobial resistance. The contract was awarded through the Department of Health and Human Services' Fiscal Year 2021 FDA Broad Agency Announcement for Advanced Research and Development of...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $103,007.40 firm fixed price purchase order contract to The Johns Hopkins University, a private non-profit university located in Baltimore, Maryland. The contract has no set-aside designation and was awarded on September 7, 2018 with a completion date of January 10, 2020. As a leading research institution, The Johns Hopkins University has a history of providing the U.S. government...
The U.S. National Institute on Aging, a civilian agency, awarded a $21,960.00 firm fixed price purchase order contract for laboratory services to The Johns Hopkins University, a private nonprofit research university. The contract has an ultimate completion date of October 17, 2024 and was awarded on September 25, 2022 with no set-aside designation. The Johns Hopkins University is a longstanding provider of biomedical research, public health, engineering, and scientific analysis services to...

This $323,940.07 firm fixed-price definitive contract was awarded by the Food and Drug Administration (FDA) to The Johns Hopkins University, a private research university. The contract is for the "Prediction of Pesticides in Foods Using High Resolution Mass Spectrometry and Artificial Intelligence/Machine Learning Workflows for Enforcement and Risk Assessment," with an ultimate completion date of August 26, 2026. No set-aside was used for this award. The Johns Hopkins University has a strong track record of providing federal agencies like the NIH, CDC, DoD, and DoJ with services such as biomedical research, public health initiatives, and scientific analysis. This contract supports the FDA's mission to advance food safety and public health through the application of advanced analytical techniques and machine learning.

Generated 8/28/24, 11:37 AM